Skip to main content
Screener/Healthcare/Biotechnology

AMLX — Amylyx Pharmaceuticals, Inc.

NASDAQ
$31.08-1.93 (-5.85%)
Mid CapUnder $50HealthcareDividend StockFastest Growing
$10.83
$41.14
$30.89
$33.02
EPS (TTM)$-1.48
P/E Ratio-10.65
Dividend Yield2.64%
Market Cap$3.63B
Volume553K
Prev Close$33.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$41.3M$-0.37——
Q4 '25$0-$33.0M$-0.28——
Q3 '25$0-$34.4M$-0.37——
Q2 '25$0-$41.4M$-0.46——
Q1 '25$0-$35.9M$-0.42——
Q4 '24-$665K-$37.5M$-0.55100.0%5646.0%
Q3 '24$416K-$72.7M$-1.07-94.5%-17476.9%
Q2 '24-$1.0M-$72.7M$-1.07845.5%7106.5%
Get Your Daily Market Recap